Back to Journals » Eye and Brain » Volume 11

Giant cell arteritis: early diagnosis is key

Authors Baig IF, Pascoe AR, Kini A, Lee AG

Received 14 August 2018

Accepted for publication 27 November 2018

Published 17 January 2019 Volume 2019:11 Pages 1—12

DOI https://doi.org/10.2147/EB.S170388

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Colin Mak

Peer reviewer comments 2

Editor who approved publication: Professor Margaret Wong-Riley


Video abstract presented by Andrew G Lee

Views: 283

Iyza F Baig,1 Alexis R Pascoe,1 Ashwini Kini,2 Andrew G Lee2–9

1McGovern Medical School, The University of Texas Health Science Center in Houston, Houston, TX, USA; 2Department of Ophthalmology, Blanton Eye Institute, Houston Methodist Hospital, Houston, TX, USA; 3Department of Ophthalmology, Baylor College of Medicine, Houston, TX, USA; 4Department of Ophthalmology, 5Department of Neurology, 6Department of Neurosurgery, Weill Cornell Medical College, Houston, TX, USA; 7The University of Texas Medical Branch, Galveston, TX, USA; 8The University of Texas MD Anderson Cancer Center, Houston, TX, USA; 9Ophthalmology, The University of Iowa Hospitals and Clinics, Iowa City, IA, USA

Abstract: Giant cell arteritis (GCA) is an inflammatory vasculitis typically affecting elderly that can potentially cause vision loss. Studies have demonstrated that early recognition and initiation of treatment can improve visual prognosis in patients with GCA. This review addresses the benefits of early diagnosis and treatment, and discusses the available treatment options to manage the disease.

Keywords: giant cell arteritis, imaging in GCA, laboratory values in GCA, steroids in GCA, steroid-sparing agents in GCA


Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]